EU launches second probe into alleged disparagement in pharma market
The European Commission has opened an abuse of dominance probe into Vifor Pharma for allegedly spreading misinformation about its closest competitor on the market for intravenous iron treatment.
To read more
Subscribe to Global Competition Review
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now